OCUL (STOCKS)
Ocular Therapeutix, Inc.
$10.099300
-0.130700 (-1.28%)
Prev close: $10.230000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Pravin U. Dugel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,701.35M
- Employees
- 274
- P/E (TTM)
- -7.15
- P/B (TTM)
- 4.32
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $52.05M |
| Benefits Costs and Expenses | $356.13M |
| Cost Of Revenue | $6.71M |
| Costs And Expenses | $365.96M |
| Gross Profit | $45.35M |
| Nonoperating Income/Loss | $12.46M |
| Operating Expenses | $359.25M |
| Research and Development | $223.51M |
| Other Operating Expenses | $135.74M |
| Operating Income/Loss | -$313.91M |
| Income/Loss From Continuing Operations After Tax | -$301.45M |
| Income/Loss From Continuing Operations Before Tax | -$304.07M |
| Net Income/Loss | -$301.45M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$301.45M |
| Net Income/Loss Available To Common Stockholders, Basic | -$301.45M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.40 |
| Diluted Earnings Per Share | -$1.40 |
| Basic Average Shares | 644,856,400 |
| Diluted Average Shares | 644,856,400 |
| Assets | $671.32M |
| Current Assets | $644.43M |
| Inventory | $3.83M |
| Other Current Assets | $640.60M |
| Noncurrent Assets | $26.89M |
| Fixed Assets | $19.46M |
| Other Non-current Assets | $7.43M |
| Liabilities | $151.28M |
| Current Liabilities | $49.17M |
| Accounts Payable | $7.00M |
| Wages | $14.17M |
| Other Current Liabilities | $28.01M |
| Noncurrent Liabilities | $102.10M |
| Equity | $520.04M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $520.04M |
| Liabilities And Equity | $671.32M |
| Net Cash Flow From Operating Activities | -$238.24M |
| Net Cash Flow From Operating Activities, Continuing | -$238.24M |
| Net Cash Flow From Investing Activities | -$16.86M |
| Net Cash Flow From Investing Activities, Continuing | -$16.86M |
| Net Cash Flow From Financing Activities | $462.61M |
| Net Cash Flow From Financing Activities, Continuing | $462.61M |
| Net Cash Flow | $207.51M |
| Net Cash Flow, Continuing | $207.51M |
| Comprehensive Income/Loss | -$301.45M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$301.45M |
| Other Comprehensive Income/Loss | $0.00 |